Menopausal and reproductive factors and risk of age-related macular degeneration

Archives of Ophthalmology

Volumn 126, Issue 4, 2008, Pages 519-524

  Feskanich, Diane ^a   Cho, Eunyoung ^a   Schaumberg, Debra A ^a,b   Colditz, Graham A ^a,c   Hankinson, Susan E ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; HORMONE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE DISTRIBUTION; ANAMNESIS; ARTICLE; CALCULATION; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EXPOSURE; DRUG POTENTIATION; FEMALE; HORMONAL THERAPY; HUMAN; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSAL SYNDROME; MENOPAUSE; PARITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REPRODUCTION; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; TREATMENT DURATION; VISUAL ACUITY;

ADULT; CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MACULAR DEGENERATION; MENARCHE; MENOPAUSE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; REPRODUCTIVE HISTORY; RISK FACTORS; UNITED STATES; VISUAL ACUITY; WOMEN'S HEALTH;

EID: 42249098998     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.4.519     Document Type: Article

References (38)

1. Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol. 1999;128(1):45-53.
2. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564-572.
3. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308(5720):385-389.
4. Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science. 2006;314(5801):989-992.
5. Klaver CC, Wolfs RC, Assink JJ, Van Duijin CM, Hofman A, de Jong PT. Genetic risk of age-related maculopathy: population-based familial aggregation study. Arch Ophthalmol. 1998;116(12):1646-1651.
6. Tomany SC, Wang JJ, Van Leeuwen R, et al. Risk factors for incident age-related macular degeneration. Ophthalmology. 2004;111(7):1280-1287.
7. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99(6):933-943.
8. Javitt JC, Zhou Z, Maguire MG, Fine SL, Willke RJ. Incidence of exudative age-related macular degeneration among elderly Americans. Ophthalmology. 2003;110(8):1534-1539.
9. Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol. 1999;6(2):125-143.
10. Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 2000;130(5):658-663.
11. Sivaprasad S, Bailey TA, Chong VNH. Bruch's membrane and the vascular intima. Clin Experiment Ophthalmol. 2005;33(5):518-523.
12. Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 1992;110(12):1701- 1708.
13. Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration. Aust N Z J Ophthalmol. 1997;25(suppl 1):S13-S15.
14. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. Ophthalmology. 2000;107(12):2224-2232.
15. Klein BEK, Klein R, Lee KE. Reproductive exposure, incident age-related cataracts, and age-related maculopathy in women: the Beaver Dam Eye Study. Am J Ophthalmol. 2000;130(3):322-326.
16. Snow KK, Cote J, Weining Y, Davis NJ, Seddon JM. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol. 2002;134(6):842-848.
17. Abramov Y, Borik S, Yahalom C, et al. The effect of hormone therapy on the risk for age-related maculopathy in postmenopausal women. Menopause. 2004;11(1):62-68.
18. Nirmalan PK, Katz J, Robin AL, et al. Female reproductive factors and eye disease in rural south Indian population: the Aravind Comprehensive Eye Survey. Invest Ophthalmol Vis Sci. 2004;45(12):4273-4276.
19. Defay R, Pinchinat S, Lumbroso S, Sutan C, Delcourt C; POLA Study Group. Sex steroids and age-related macular degeneration in older French women: the POLA Study. Ann Epidemiol. 2004;14(3):202-208.
20. Freeman EE, Munoz B, Bresslar SB, West SK. Hormone replacement therapy, reproductive factors, and age-related macular degeneration: the Salisbury Eye Evaluation Project. Ophthalmic Epidemiol. 2005;12(1):37-45.
21. Fraser-Bell S, Wu J, Klein R, Azen SP, Varma R; Los Angeles Latino Eye Study Group. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos. Am J Ophthalmol. 2006;141(1):79-87.
22. Haan MN, Klein R, Klein BE, et al. Hormone therapy and age-related macular degeneration. Arch Ophthalmol. 2006;124(7):988-992.
23. Colditz GA, Stampfer MJ, Willett WC, et al. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol. 1987;126(2):319-325.
24. Cho E, Hankinson SE, Willett WC, et al. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch Ophthalmol. 2000;118(5):681-688.
25. Cho E, Stampfer MJ, Seddon JM, et al. Prospective study of zinc intake and the risk of age-related macular degeneration. Ann Epidemiol. 2001;11(5):328-336.
26. Cho E, Hung S, Willett WC, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr. 2001;73(2):209-218.
27. Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol. 2004;122(6):883-892.
28. Ogueta SB, Schwartz SD, Yamashita CK, Farber DB. Estrogen receptor in the human eye. Invest Ophthalmol Vis Sci. 1999;40(9):1906-1911.
29. Munaut C, Lambert V, Noel A, et al. Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol. 2001;85(7):877-882.
30. Liang F-Q, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells. Exp Eye Res. 2003;76(4):397-403.
31. Yu X, Tang Y, Li F, et al. Protection against hydrogen peroxide-induced cell death in cultured human retinal pigment epithelial cells by 17β-estradiol: a differential gene expression profile. Mech Ageing Dev. 2005;126(11):1135-1145.
32. Bhavnani BR, Cecutti A, Gerulath A, Woolever AC, Berco M. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women. Menopause. 2001;8(6):408-419.
33. Curcio CA, Millikan CL, Kruth HS. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001;42(1):265-274.
34. Leung H, Wang JJ, Rochtchina E, et al. Relationships between age, blood pressure and retinal vessel diameters in an older population. Invest Ophthalmol Vis Sci. 2003;44(7):2900-2904.
35. Leung H, Wang JJ, Rochtchina E, Wong TY, Klein R, Mitchell P. Does hormone replacement therapy influence retinal microvascular caliber? Microvasc Res. 2004;67(1):48-54.
36. Marin-Castaño ME, Elliot SJ, Potier M, et al. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2003;44(1):50-59.
37. Rakic J-M, Lambert V, Deprez M, Foidart J-M, Noel A, Munaut C. Estrogens reduce the expression of YKL-40 in the retina: implications for eye and joint diseases. Invest Ophthalmol Vis Sci. 2003;44(4):1740-1746.
38. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy. Ophthalmology. 2002;109(10):1767-1779.